JP2008534533A5 - - Google Patents

Download PDF

Info

Publication number
JP2008534533A5
JP2008534533A5 JP2008503397A JP2008503397A JP2008534533A5 JP 2008534533 A5 JP2008534533 A5 JP 2008534533A5 JP 2008503397 A JP2008503397 A JP 2008503397A JP 2008503397 A JP2008503397 A JP 2008503397A JP 2008534533 A5 JP2008534533 A5 JP 2008534533A5
Authority
JP
Japan
Prior art keywords
administration system
steroid hormone
administration
steroid
ment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008503397A
Other languages
English (en)
Japanese (ja)
Other versions
JP5843416B2 (ja
JP2008534533A (ja
Filing date
Publication date
Priority claimed from DE102005015128A external-priority patent/DE102005015128B4/de
Application filed filed Critical
Publication of JP2008534533A publication Critical patent/JP2008534533A/ja
Publication of JP2008534533A5 publication Critical patent/JP2008534533A5/ja
Application granted granted Critical
Publication of JP5843416B2 publication Critical patent/JP5843416B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008503397A 2005-03-31 2006-03-15 ステロイドホルモンを含むタブレット Expired - Fee Related JP5843416B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005015128.0 2005-03-31
DE102005015128A DE102005015128B4 (de) 2005-03-31 2005-03-31 Wafer enthaltend Steroidhormone
PCT/EP2006/002358 WO2006102990A2 (de) 2005-03-31 2006-03-15 Wafer enthaltend steroidhormone

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013087238A Division JP2013155190A (ja) 2005-03-31 2013-04-18 ステロイドホルモンを含むタブレット

Publications (3)

Publication Number Publication Date
JP2008534533A JP2008534533A (ja) 2008-08-28
JP2008534533A5 true JP2008534533A5 (enExample) 2009-04-09
JP5843416B2 JP5843416B2 (ja) 2016-01-13

Family

ID=36998911

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008503397A Expired - Fee Related JP5843416B2 (ja) 2005-03-31 2006-03-15 ステロイドホルモンを含むタブレット
JP2013087238A Pending JP2013155190A (ja) 2005-03-31 2013-04-18 ステロイドホルモンを含むタブレット

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013087238A Pending JP2013155190A (ja) 2005-03-31 2013-04-18 ステロイドホルモンを含むタブレット

Country Status (26)

Country Link
US (2) US9763960B2 (enExample)
EP (1) EP1863444B1 (enExample)
JP (2) JP5843416B2 (enExample)
KR (2) KR20140063740A (enExample)
CN (2) CN104983669B (enExample)
AR (1) AR054245A1 (enExample)
AU (1) AU2006228820B2 (enExample)
BR (1) BRPI0609601A2 (enExample)
CA (1) CA2598892C (enExample)
CR (1) CR9468A (enExample)
DE (1) DE102005015128B4 (enExample)
DO (1) DOP2006000070A (enExample)
EA (1) EA014183B1 (enExample)
GT (1) GT200600126A (enExample)
IL (1) IL186081A0 (enExample)
MX (1) MX2007012081A (enExample)
NO (1) NO20075404L (enExample)
NZ (1) NZ592882A (enExample)
PE (1) PE20061194A1 (enExample)
SG (1) SG179459A1 (enExample)
SV (1) SV2008002466A (enExample)
TW (1) TWI393576B (enExample)
UA (1) UA92011C2 (enExample)
UY (1) UY29441A1 (enExample)
WO (1) WO2006102990A2 (enExample)
ZA (1) ZA200706116B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8492369B2 (en) 2010-04-12 2013-07-23 Clarus Therapeutics Inc Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
US8241664B2 (en) 2005-04-15 2012-08-14 Clarus Therapeutics, Inc Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
DE102006027796A1 (de) * 2006-06-16 2007-12-20 Lts Lohmann Therapie-Systeme Ag Estrogen-Gestagen-Kombinationen
NZ586666A (en) * 2008-02-13 2012-04-27 Bayer Schering Pharma Ag Estradiol-containing drug delivery system
KR20100117603A (ko) * 2008-02-13 2010-11-03 바이엘 쉐링 파마 악티엔게젤샤프트 안정화 효과를 갖는 약물 전달 시스템
TW201008569A (en) * 2008-08-08 2010-03-01 Bayer Schering Pharma Ag Progestin-containing drug delivery system
CA2744127A1 (en) * 2008-11-21 2010-05-27 Bayer Schering Pharma Aktiengesellschaft Drug delivery system
US12186426B2 (en) 2009-10-30 2025-01-07 Ix Biopharma Ltd. Solid dosage form
EP2493457B1 (en) 2009-10-30 2017-08-09 IX Biopharma Ltd Fast dissolving solid dosage form
US10806703B2 (en) * 2012-01-20 2020-10-20 Lts Lohmann Therapie-System Ag Transmucosal administration system for a pharmaceutical drug
AU2012385956B2 (en) 2012-07-23 2017-03-30 Crayola, Llc Dissolvable films and methods of using the same
DE102017112527B4 (de) * 2017-06-07 2019-01-03 Lts Lohmann Therapie-Systeme Ag Schnell zerfallende Schaumwafer mit hohem Flächengewicht
MX2020008147A (es) * 2018-02-02 2020-10-28 Acerus Biopharma Inc Metodos de terapia de testosterona.

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB981372A (en) * 1960-05-04 1965-01-27 Pfizer Ltd Pharmaceutical formulations for oral administration to animals
US4136162A (en) 1974-07-05 1979-01-23 Schering Aktiengesellschaft Medicament carriers in the form of film having active substance incorporated therein
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
DE69312487T2 (de) * 1992-05-18 1997-11-27 Minnesota Mining & Mfg Einrichtung zur transmucosalen wirkstoffabgabe
DE19646392A1 (de) * 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
DE19847252B4 (de) * 1998-10-02 2004-02-12 Jenapharm Gmbh & Co. Kg Bukkal applizierbare bioadhäsive Systeme mit zeitlich gesteuerter Wirkstofffreisetzung enthaltend Testosteronester und fakultativ zusätzlich Testosteron
US6552024B1 (en) * 1999-01-21 2003-04-22 Lavipharm Laboratories Inc. Compositions and methods for mucosal delivery
US6264981B1 (en) * 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
US20030092658A1 (en) * 2001-02-02 2003-05-15 Meyers Rachel E. Novel human enzyme family members and uses thereof
AU2001273231A1 (en) * 2000-07-06 2002-01-21 Delsys Pharmaceutical Corporation Method for formulating healthcare products with enhanced stability
GB0100760D0 (en) * 2001-01-11 2001-02-21 Biocompatibles Ltd Drug delivery from stents
US6585997B2 (en) * 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
FR2832311B1 (fr) * 2001-11-21 2004-04-16 Besins Int Belgique Poudre filmogene, compositions la comprenant, leurs procedes de preparation et leurs utilisations
JO2492B1 (en) * 2003-04-28 2009-10-05 شيرينج ايه جي A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients
JP2007500729A (ja) * 2003-07-31 2007-01-18 アイバックス コーポレイション 雄性及び雌性の性機能障害の治療方法
PL1670433T3 (pl) * 2003-10-10 2013-03-29 Ferring Bv Przezskórna formulacja farmaceutyczna do zmniejszania pozostałości na skórze

Similar Documents

Publication Publication Date Title
US5676968A (en) Transdermal therapeutic systems with crystallization inhibitors
AU712692B2 (en) Transdermal therapeutic systems containing crystallization inhibitors
JP2008534533A5 (enExample)
CN1137689C (zh) 提高甾体化合物稳定性的药物释放组合物
JP2005500299A5 (enExample)
JP2013155190A (ja) ステロイドホルモンを含むタブレット
TW200808382A (en) Film-shaped drug forms for use in the oral cavity (wafers)
JP4132679B2 (ja) 経皮系のための作用物質含有ラミネート
JP2011511816A (ja) 安定化効果を有する薬物送達システム
RS61812B1 (sr) Oralno-disperzibilna tableta koja sadrži estetriol
JP2019517497A5 (enExample)
JP2019123756A (ja) 抗黄体ホルモンの無毒送達のための組成物および方法
US20120245552A1 (en) Combination Therapy
JP2020530461A (ja) 酢酸アビラテロン及びダルロタミドを含む医薬組成物
JP2011506607A (ja) 免疫炎症性障害の処置のための治療法
JPWO2021016208A5 (enExample)
JP2014508809A5 (enExample)
CN108606963B (zh) 含有屈螺酮和雌激素的复方避孕贴、制备方法及应用
HK1116055A (en) Tablet containing steroid hormones
IE20150140A1 (en) Use of antagonists to the nuclear steroid receptor alone or in combination as direct antiviral agents to inhibit alphavirus, togaviridae, arenaviridae, filoviridae, bunyaviridae, flaviviridae and rhabdoviridae
TW200534866A (en) Compositions and methods of enhanced transdermal delivery of steroid compounds and preparation methods thereof
JP2004506006A (ja) 輸送剤としてのステロイドホルモン